EUVIMEDEUVIMED entdecken
Crossref

Isoquinoline‐Fused Benzimidazoles Based Highly Selective Fluorogenic Receptors for Detection of Cu 2+ , Fe 3+ , and Cl − Ions: Cytotoxicity and HepG2 Cancer Cell Imaging

Parvathavarthini Murugaperumal, Venkatramani Sriram, Sengottuvelan Nallathambi iD, Siva Ayyanar, Ashokkumar Balasubramaniem

Luminescence · 2025

DOI: 10.1002/bio.70137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Parvathavarthini Murugaperumal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial Chemistry, Alagappa University, Karaikudi, India. Hauptthemen laut MEDLINE: Benzimidazoles, Copper, Isoquinolines, Fluorescent Dyes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: RUSA-Phase 2.0.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An efficient isoquinoline‐fused benzimidazole–based “turn‐on” fluorescence receptor 9,10‐bis(2‐phenylhydrazineyl)‐7H‐benzo[de]imidazo[2,1‐a]isoquinolin‐7‐one OXPH(ANQ) and “turn‐off” fluorescence receptor 9,10‐bis((3‐(1H‐imidazol‐1‐yl)propyl)amino)‐7H‐benzo[de]imidazo[2,1‐a]isoquinolin‐7‐one OXPID(ANQ) were prepared and characterized by various spectral techniques. The sensing behavior of receptors was demonstrated by UV–vis and fluorescence experiments, and naked‐eye detection exhibited prominent visual emission color change toward Cu 2+ /Cl − and Fe 3+ over other testing cations/anions in DMSO:water (9:1, ν/v) solution. The 1:1 binding stoichiometry was confirmed by Job's plot, FT‐IR, mass spectral titration, and also DFT studies with target ions as evidence for the binding nature of OXPH(ANQ) / OXPID(ANQ) with Cu 2+ /Cl − and Fe 3+ ions, respectively. Limits of detection for OXPH(ANQ) with Cu 2+ /Cl − ions were of 4.50 and 4.91 μM, and OXPID(ANQ) with Fe 3+ ions were of 5.06 μM. Interestingly, chemosensors OXPH(ANQ) / OXPID(ANQ) applied to intracellular image of Cu 2+ /Cl − and Fe 3+ ions in living cells of HepG2 (Liver cancer cells) via confocal fluorescence microscopy technique at physiological environmental and also utilized for antimicrobial activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesCopperIsoquinolinesFluorescent DyesChloridesAntineoplastic AgentsIronFerric CompoundsHumansHep G2 CellsMolecular StructureCell SurvivalSpectrometry, FluorescenceIonsOptical Imaging

Stichwörter der Autor:innen

CHEF/CHEQ mechanismCu2+, Fe3+, and Cl− ion detectionHepG2 cell lineacenaphthoquinonechemosensor

Substanzen

BenzimidazolesCopperIsoquinolinesFluorescent DyesChloridesisoquinolineAntineoplastic AgentsIonsIronFerric Compounds

Autor:innen und Institutionen

  • Department of Industrial Chemistry, Alagappa University, Karaikudi, India.
  • Department of Chemistry, Centre for Distance and Online Education (CDOE), Alagappa University, Karaikudi, India.
  • Department of Inorganic Chemistry, Madurai Kamaraj University, Madurai, India.
  • Department of Genetic Engineering, Madurai Kamaraj University, Madurai, India.

ORCID-Profile: Sengottuvelan Nallathambi

Förderung

  • RUSA-Phase 2.0

Zitieren

APA

Murugaperumal, P., Sriram, V., Nallathambi, S., Ayyanar, S., & Balasubramaniem, A. (2025). Isoquinoline‐Fused Benzimidazoles Based Highly Selective Fluorogenic Receptors for Detection of Cu 2+ , Fe 3+ , and Cl − Ions: Cytotoxicity and HepG2 Cancer Cell Imaging. Luminescence. https://doi.org/10.1002/bio.70137

Vancouver

Murugaperumal P, Sriram V, Nallathambi S, Ayyanar S, Balasubramaniem A. Isoquinoline‐Fused Benzimidazoles Based Highly Selective Fluorogenic Receptors for Detection of Cu 2+ , Fe 3+ , and Cl − Ions: Cytotoxicity and HepG2 Cancer Cell Imaging. Luminescence. 2025. doi:10.1002/bio.70137

BibTeX
@article{Murugaperumal2025,
  author = {Murugaperumal, Parvathavarthini and Sriram, Venkatramani and Nallathambi, Sengottuvelan and Ayyanar, Siva and Balasubramaniem, Ashokkumar},
  title = {Isoquinoline‐Fused Benzimidazoles Based Highly Selective Fluorogenic Receptors for Detection of Cu 2+ , Fe 3+ , and Cl − Ions: Cytotoxicity and HepG2 Cancer Cell Imaging},
  journal = {Luminescence},
  year = {2025},
  doi = {10.1002/bio.70137}
}
Kostenlos starten →